850424-09-8

Basic information

• Product Name: Carbamic acid, (2-formyl-4-methoxyphenyl)-, ethyl ester
• CAS NO: 850424-09-8
• Molecular Formula: C11H13NO4
• Molecular Weight: 223.229
• Mol File: 850424-09-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (2-formyl-4-methoxyphenyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (2-formyl-4-methoxyphenyl)-, ethyl ester(850424-09-8)
• EPA Substance Registry System: Carbamic acid, (2-formyl-4-methoxyphenyl)-, ethyl ester(850424-09-8)

Safety Data

• Hazardous Substances Data: 850424-09-8(Hazardous Substances Data)

Upstream product

• 55414-72-7 (2-amino-5-methoxyphenyl)methanol 
• 6705-03-9 2-Amino-5-methoxybenzoic acid 
• 73428-02-1 5-methoxy-2-nitrobenzaldehyde ethylene acetal 
• 64389-34-0 5-methoxy-2-aminobenzaldehyde ethylene acetal 
• 20357-24-8 5-methoxy-2-nitro-benzaldehyde 
• 42454-06-8 2-nitro-5-hydroxybenzaldehyde 

Downstream Products

• 850424-15-6 C₁₉H₂₁N₃O 
• 850424-16-7 C₁₈H₁₉N₃O 
• 1361129-30-7 2-(4-isopropylphenylamino)quinazolin-6-ol 
• 1374336-64-7 N-(4-isopropylphenyl)-6-methoxyquinazolin-2-amine 
• 850424-11-2 2-chloro-6-methoxyquinazoline 
• 1361129-27-2 C₂₅H₂₅N₅O₂ 
• 850424-10-1 6-methoxyquinazolin-2-ol 

Relevant articles and documents

Access to 5,6-Spirocycles Bearing Three Contiguous Stereocenters via Pd-Catalyzed Stereoselective [4 + 2] Cycloaddition of Azadienes

We present herein a highly diastereo- and enantioselective Pd-catalyzed [4 + 2] cycloaddition of benzofuran-derived azadienes with vinyl benzoxazinanones, which represents a rare highly stereoselective cycloaddition of this class of fused azadienes as a two-atom synthon. The use of a phosphoramidite ligand bearing a chiral secondary amine with a simple biphenyl backbone proved to be the key to construct the novel spirocyclic tetrahydroquinoline scaffold containing three contiguous stereocenters as a single diastereomer in high enantioselectivity.

BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR

The present disclosure describes biaryl triazole compounds, as well as their compositions and methods of use. The compounds inhibit the activity of macrophage migration inhibitory factor and are useful for the treatment of diseases, e.g., inflammatory dis